Stay updated on Pembrolizumab for Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Head and Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.2%
    Check dated 2025-06-20T18:26:07.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T16:04:08.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-06T10:07:17.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.4%
    Check dated 2025-05-30T04:50:15.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-23T02:13:11.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page has removed a detailed citation regarding a study on pembrolizumab and cetuximab for head and neck cancer, which is a significant loss of core content.
    Difference
    0.2%
    Check dated 2025-05-15T21:13:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.